Dudley & Shanley’s Pfizer PFE Stock Holding History

Dudley & Shanley’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.71M	Hold	165,000	–	–	0.75%	31
2026 Q2	$3.97M	Buy	+165,000	New	+$4.32M	0.6%	31
2022 Q4	–	Sell	-6,000	Closed	-$263K	–	35
2022 Q3	$263K	Hold	6,000	–	–	0.07%	26
2022 Q2	$315K	Hold	6,000	–	–	0.07%	28
2022 Q1	$311K	Hold	6,000	–	–	0.06%	30
2021 Q4	$354K	Hold	6,000	–	–	0.06%	32
2021 Q3	$258K	Hold	6,000	–	–	0.05%	31
2021 Q2	$235K	Hold	6,000	–	–	0.04%	31
2021 Q1	$217K	Buy	+6,000	New	+$213K	0.04%	30

Other funds holding PFE

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

VWM

Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return

Avanza Fonder Stockholm, Sweden $5.23B AUM 33.79% 1-Year Est. Return

Dudley & Shanley's PFE Position: Q3 2026 in Review

Dudley & Shanley held its Pfizer (PFE) position steady in Q3 2026 at 165,000 shares worth $4.71M. The position accounts for 0.75% of the portfolio, ranked #31.

Dudley & Shanley first reported a position in PFE in Q1 2021 and has held it in 9 quarters since. 331 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Dudley & Shanley held 165,000 shares of Pfizer worth $4.71M as of Q3 2026.
Dudley & Shanley left its Pfizer share count unchanged in Q3 2026.
Pfizer made up 0.75% of Dudley & Shanley's portfolio in Q3 2026, its #31 holding.
Dudley & Shanley first reported a position in Pfizer in Q1 2021 and has held it in 9 quarters since.
331 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Dudley & Shanley's 13F filing for Q3 2026, filed 6 Oct 2026.